{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:23:42Z","timestamp":1793291022295,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018982","name":"Fondazione Bambino Gesu Onlus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["2016-02361576"],"award-info":[{"award-number":["2016-02361576"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5 \\u00D7 1000"],"award-info":[{"award-number":["5 \\u00D7 1000"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.kint.2023.06.013","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T02:15:36Z","timestamp":1687918536000},"page":"577-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing\/steroid-dependent nephrotic syndrome"],"prefix":"10.1016","volume":"104","author":[{"given":"Manuela","family":"Colucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Carsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lugani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Rav\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ravani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"Ghiggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vivarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2023.06.013_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","article-title":"Idiopathic nephrotic syndrome in children","volume":"392","author":"Noone","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2023.06.013_bib2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2023.06.013_bib3","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2215\/CJN.08500815","article-title":"Anti-CD20 antibodies for idiopathic nephrotic syndrome in children","volume":"11","author":"Ravani","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib4","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1681\/ASN.2021040561","article-title":"Human or chimeric monoclonal anti-CD20 antibodies for children with nephrotic syndrome: a superiority randomized trial","volume":"32","author":"Ravani","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00467-020-04609-0","article-title":"Rituximab in children with steroid sensitive nephrotic syndrome: in quest of the optimal regimen","volume":"36","author":"Chan","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.2021111472","article-title":"Long-term efficacy and safety of repeated rituximab to maintain remission in idiopathic childhood nephrotic syndrome: an international study","volume":"33","author":"Chan","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib7","first-page":"gfac228","article-title":"Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects","author":"Sinha","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.06.013_bib8","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3389\/fimmu.2019.01653","article-title":"Prolonged impairment of immunological memory after anti-CD20 treatment in pediatric idiopathic nephrotic syndrome","volume":"10","author":"Colucci","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.06.013_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00467-019-04398-1","article-title":"Immunoglobulin serum levels in rituximab-treated patients with steroid-dependent nephrotic syndrome","volume":"35","author":"Parmentier","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00467-021-05345-9","article-title":"Hypogammaglobulinaemia following rituximab therapy in childhood nephrotic syndrome","volume":"37","author":"Chan","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.kint.2019.09.033","article-title":"Both the rituximab dose and maintenance immunosuppression in steroid-dependent\/frequently-relapsing nephrotic syndrome have important effects on outcomes","volume":"97","author":"Chan","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.06.013_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1681\/ASN.2021050643","article-title":"Mycophenolate mofetil after rituximab for childhood-onset complicated frequently-relapsing or steroid-dependent nephrotic syndrome","volume":"33","author":"Iijima","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00467-010-1465-6","article-title":"Rituximab efficiency in children with steroid-dependent nephrotic syndrome","volume":"25","author":"Sellier-Leclerc","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","article-title":"Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery","volume":"27","author":"Sellier-Leclerc","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.06.013_bib15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1681\/ASN.2015050523","article-title":"B\u00a0cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome","volume":"27","author":"Colucci","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41390-018-0088-7","article-title":"Rituximab modulates T- and B-lymphocyte subsets and urinary CD80 excretion in patients with steroid-dependent nephrotic syndrome","volume":"84","author":"Bhatia","year":"2018","journal-title":"Pediatr Res"},{"key":"10.1016\/j.kint.2023.06.013_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726428","article-title":"CyTOF-enabled analysis identifies class-switched B cells as the main lymphocyte subset associated with disease relapse in children with idiopathic nephrotic syndrome","volume":"12","author":"Fribourg","year":"2021","journal-title":"Front Immunol"},{"issue":"4S","key":"10.1016\/j.kint.2023.06.013_bib18","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2023.06.013_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ekir.2019.12.015","article-title":"Prediction of short- and long-term outcomes in childhood nephrotic syndrome","volume":"5","author":"Carter","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2023.06.013_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10157-020-02002-7","article-title":"Clinical characteristics of patients with early relapse during B-cell depletion after rituximab treatment for complicated steroid-dependent nephrotic syndrome","volume":"25","author":"Fujinaga","year":"2021","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2215\/CJN.08570722","article-title":"Use of rituximab in childhood idiopathic nephrotic syndrome","volume":"18","author":"Chan","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib22","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1681\/ASN.2021060794","article-title":"Discovery of autoantibodies targeting nephrin in minimal change disease supports a novel autoimmune etiology","volume":"33","author":"Watts","year":"2022","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib24","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","article-title":"Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood","volume":"141","author":"Blanco","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.kint.2023.06.013_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/eji.201646642","article-title":"Human B-cell memory is shaped by age- and tissue-specific T-independent and GC-dependent events","volume":"47","author":"Aranburu","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.kint.2023.06.013_bib26","doi-asserted-by":"crossref","first-page":"782","DOI":"10.3389\/fimmu.2019.00782","article-title":"B\u00a0cell reconstitution and influencing factors after hematopoietic stem cell transplantation in children","volume":"10","author":"van der Maas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.06.013_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.684147","article-title":"Modeling influencing factors in B-cell reconstitution after hematopoietic stem cell transplantation in children","volume":"12","author":"van der Maas","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.06.013_bib28","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/ndt\/gfu209","article-title":"Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance","volume":"29","author":"Guitard","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.06.013_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00467-018-4095-z","article-title":"B\u00a0cell phenotype in pediatric idiopathic nephrotic syndrome","volume":"34","author":"Colucci","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ndt\/gfaa279","article-title":"Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults","volume":"36","author":"Oniszczuk","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2023.06.013_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823204","article-title":"B-cell dysregulation in idiopathic nephrotic syndrome: what we know and what we need to discover","volume":"13","author":"Colucci","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.kint.2023.06.013_bib32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1681\/ASN.2017040367","article-title":"Targeting B cells and plasma cells in glomerular diseases: translational perspectives","volume":"29","author":"Schrezenmeier","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2023.06.013_bib33","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2014-07-585976","article-title":"Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers","volume":"124","author":"Wallin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.kint.2023.06.013_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-019-1595-3","article-title":"Analysis of the B cell receptor repertoire in six immune-mediated diseases","volume":"574","author":"Bashford-Rogers","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.kint.2023.06.013_bib35","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1212\/NXI.0000000000000845","article-title":"Tailoring B cell depletion therapy in MS according to memory B cell monitoring","volume":"7","author":"Novi","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823004660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253823004660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:09:55Z","timestamp":1778627395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253823004660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0085253823004660"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2023.06.013","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age and memory B cells at baseline are associated with risk of relapse and memory B-cell reappearance following anti-CD20 treatment in pediatric frequently-relapsing\/steroid-dependent nephrotic syndrome","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2023.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}